Sutezolid

Partners: Bill & Melinda Gates Medical Research Institute

Background:

Sutezolid is in the same class of drugs as linezolid (oxazolidinones), which is used in some countries as a treatment option for drug-resistant TB (DR-TB). Tests conducted over the past decade have indicated that sutezolid may have a better therapeutic potential than linezolid.  

Phase 1

Trial Components

Solo Compounds